Coordinated prospective follow-up of Lynch syndrome is able to detect the majority of incident cancers.

Cancer genetics Cancer prevention Lynch syndrome

Journal

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
ISSN: 1878-3562
Titre abrégé: Dig Liver Dis
Pays: Netherlands
ID NLM: 100958385

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 29 11 2022
revised: 28 03 2023
accepted: 28 03 2023
pubmed: 26 4 2023
medline: 26 4 2023
entrez: 25 4 2023
Statut: ppublish

Résumé

Lynch syndrome is one of the most common genetic predispositions to many cancers, most of which do not have a consensus recommendation for screening. We studied in our region the value of a systematized and coordinated follow-up program for patients with Lynch syndrome on all organs at risk. A multicenter prospective cohort evaluation was performed, from January 2016 to June 2021. One hundred and seventy-eight patients were prospectively included (104 women (58%), median age 44 years, range 35-56 years) with a median follow-up of 4 years (range 2.5-5 years), corresponding to a total of 652 patient-years. The overall cancer incidence rate was 13.80 per 1000 patient-years. Seven of nine cancers (78%) were detected during the follow-up program, with all cancers identified at an early stage. The detection rate of adenomas during colonoscopies was 24%. These preliminary data suggest that coordinated prospective follow-up of Lynch syndrome is capable of detecting the majority of incident cancers, particularly for locations not covered by an international follow-up recommendation. However, these results need to be confirmed by larger-scale studies.

Sections du résumé

BACKGROUND BACKGROUND
Lynch syndrome is one of the most common genetic predispositions to many cancers, most of which do not have a consensus recommendation for screening.
AIMS OBJECTIVE
We studied in our region the value of a systematized and coordinated follow-up program for patients with Lynch syndrome on all organs at risk.
METHODS METHODS
A multicenter prospective cohort evaluation was performed, from January 2016 to June 2021.
RESULTS RESULTS
One hundred and seventy-eight patients were prospectively included (104 women (58%), median age 44 years, range 35-56 years) with a median follow-up of 4 years (range 2.5-5 years), corresponding to a total of 652 patient-years. The overall cancer incidence rate was 13.80 per 1000 patient-years. Seven of nine cancers (78%) were detected during the follow-up program, with all cancers identified at an early stage. The detection rate of adenomas during colonoscopies was 24%.
CONCLUSION CONCLUSIONS
These preliminary data suggest that coordinated prospective follow-up of Lynch syndrome is capable of detecting the majority of incident cancers, particularly for locations not covered by an international follow-up recommendation. However, these results need to be confirmed by larger-scale studies.

Identifiants

pubmed: 37098454
pii: S1590-8658(23)00530-3
doi: 10.1016/j.dld.2023.03.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1735-1741

Informations de copyright

Copyright © 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Auteurs

Pierre Lafeuille (P)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France. Electronic address: pierre.lafeuille@chu-lyon.fr.

Laura Calavas (L)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.

Nicolas Benech (N)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.

Naouele Raby (N)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.

Fabien Subtil (F)

Service de Biostatistique, Hospices Civils de Lyon, Lyon, France; Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, Villeurbanne, France.

Mathieu Pioche (M)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.

Jean-Christophe Saurin (JC)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.

Classifications MeSH